国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Schizosaccharomyces pombe Acetyl-CoA hydrolase (ach1), partial CSB-YP892261SXV
CSB-EP892261SXV
CSB-BP892261SXV
CSB-MP892261SXV
CSB-EP892261SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Mating-type switching protein swi1 (swi1), partial CSB-YP892262SXV
CSB-EP892262SXV
CSB-BP892262SXV
CSB-MP892262SXV
CSB-EP892262SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe PRA1-like protein (SPCC306.02c), partial CSB-YP892263SXV1
CSB-EP892263SXV1
CSB-BP892263SXV1
CSB-MP892263SXV1
CSB-EP892263SXV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Endo-xylogalacturonan hydrolase A (xghA) CSB-YP892264DPD
CSB-EP892264DPD
CSB-BP892264DPD
CSB-MP892264DPD
CSB-EP892264DPD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Neurospora crassa Heterokaryon incompatibility protein 6, OR allele (het-6), partial CSB-YP892265NHA
CSB-EP892265NHA
CSB-BP892265NHA
CSB-MP892265NHA
CSB-EP892265NHA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pleurotus sajor-caju Trehalose phosphorylase (TP), partial CSB-YP892266PNJ
CSB-EP892266PNJ
CSB-BP892266PNJ
CSB-MP892266PNJ
CSB-EP892266PNJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lanosterol 14-alpha demethylase (CYP51), partial CSB-YP892267DZN
CSB-EP892267DZN
CSB-BP892267DZN
CSB-MP892267DZN
CSB-EP892267DZN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yarrowia lipolytica pH-response regulator protein palH/RIM21 (RIM21), partial CSB-YP892268YAP1
CSB-EP892268YAP1
CSB-BP892268YAP1
CSB-MP892268YAP1
CSB-EP892268YAP1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ashbya gossypii V-type proton ATPase catalytic subunit A (VMA1), partial CSB-YP892269DOT
CSB-EP892269DOT
CSB-BP892269DOT
CSB-MP892269DOT
CSB-EP892269DOT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant 1,4-beta-D-glucan cellobiohydrolase A (cbhA) CSB-YP892270DOZ
CSB-EP892270DOZ
CSB-BP892270DOZ
CSB-MP892270DOZ
CSB-EP892270DOZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Saccharomycopsis fibuligera Orotidine 5'-phosphate decarboxylase (URA3) CSB-YP892271SAK
CSB-EP892271SAK
CSB-BP892271SAK
CSB-MP892271SAK
CSB-EP892271SAK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida albicans pH-response regulator protein palF/RIM8 (RIM8), partial CSB-YP892272CZD
CSB-EP892272CZD
CSB-BP892272CZD
CSB-MP892272CZD
CSB-EP892272CZD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida albicans Oxysterol-binding protein-like protein OBPalpha (OBPALPHA) CSB-YP892273CZD
CSB-EP892273CZD
CSB-BP892273CZD
CSB-MP892273CZD
CSB-EP892273CZD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Candida albicans Mating-type-like protein A1 (MTLA1) CSB-YP892274CZD
CSB-EP892274CZD
CSB-BP892274CZD
CSB-MP892274CZD
CSB-EP892274CZD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Emericella nidulans Pyridoxine biosynthesis protein pyroA (pyroA) CSB-YP892275EKF
CSB-EP892275EKF
CSB-BP892275EKF
CSB-MP892275EKF
CSB-EP892275EKF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Magnaporthe oryzae Calmodulin (CMD1) CSB-YP892276MPM
CSB-EP892276MPM
CSB-BP892276MPM
CSB-MP892276MPM
CSB-EP892276MPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus acidocaldarius Transcription initiation factor IIB (tfb) CSB-YP892277FOZ
CSB-EP892277FOZ
CSB-BP892277FOZ
CSB-MP892277FOZ
CSB-EP892277FOZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Arginine decarboxylase proenzyme (SSO0536) CSB-YP892278FPM
CSB-EP892278FPM
CSB-BP892278FPM
CSB-MP892278FPM
CSB-EP892278FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus V-type ATP synthase subunit E (atpE) CSB-YP892279FPM
CSB-EP892279FPM
CSB-BP892279FPM
CSB-MP892279FPM
CSB-EP892279FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sulfolobus solfataricus Ketol-acid reductoisomerase 1 (ilvC1) CSB-YP892280FPM
CSB-EP892280FPM
CSB-BP892280FPM
CSB-MP892280FPM
CSB-EP892280FPM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>